Table 2. Correlations between immunological and angiogenetic parameters in the IL-2-treated patients’ group and in the untreated patients’ group.
| Immunological and angiogenetic parameters (mean±s.d.) | IL-2 treatment | No IL-2 treatment | P-value |
|---|---|---|---|
| Tryptase | 26.18±17.70 | 19.32±9.05 | 0.04 |
| Chymase | 4.06±5.50 | 3.40±5.80 | 0.60 |
| Foxp3 | 11.80±12.25 | 6.12±9.90 | 0.02 |
| CD4 | 60.33±40.38 | 47.42±35.00 | 0.13 |
| CD8 | 90.83±30.64 | 67.11±46.57 | 0.004 |
| CD34 | 62.12±22.13 | 147.70±55.09 | 0.0001 |
| VEGF | 33.70±30.95 | 38.18±35.04 | 0.64 |
Abbreviation: IL=interleukin. Bold values indicate P<0.05.